Denis Moro-Sibilot

5PUBLICATIONS
39CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 08, 2022
Comprehensive Genome Profiling in Patients With Metastatic Non-Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 Trial.

Fabrice Barlesi, Pascale Tomasini, Maryam Karimi

|Feb 04, 2022
Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer.

Lisa Derosa, Bertrand Routy, Andrew Maltez Thomas

|Jan 24, 2022
Combination of Trastuzumab, Pertuzumab, and Docetaxel in Patients With Advanced Non-Small-Cell Lung Cancer Harboring HER2 Mutations: Results From the IFCT-1703 R2D2 Trial.

Julien Mazieres, Claire Lafitte, Charles Ricordel

|May 25, 2021
First-Line Afatinib plus Cetuximab for EGFR-Mutant Non-Small Cell Lung Cancer: Results from the Randomized Phase II IFCT-1503 ACE-Lung Study.

Alexis B Cortot, Anne Madroszyk, Etienne Giroux-Leprieur

|Mar 08, 2020
Randomized Phase II Trial Evaluating Treatment with EGFR-TKI Associated with Antiestrogen in Women with Nonsquamous Advanced-Stage NSCLC: IFCT-1003 LADIE Trial.

Julien Mazieres, Fabrice Barlesi, Isabelle Rouquette

Pageof 1

Frequent Collaborators

4 joint publications

Julien Mazieres

4 joint publications

Alexis Cortot

2 joint publications

Anne Madroszyk

2 joint publications

Judith Raimbourg